Breast tumors in patients with hyperprolactinemia
- 1 July 1982
- Vol. 50 (1) , 125-129
- https://doi.org/10.1002/1097-0142(19820701)50:1<125::aid-cncr2820500123>3.0.co;2-d
Abstract
The histology of breast lumps in five patients with hyperprolactinemia showed benign mammary dysplasia with vacuolation of acinar and duct lining cells. In two cases, foci of lobular development resembling lactating breast tissue were also noted. In the past, focal secretory change has been considered to be idiopathic, but these cases indicate a possible association with hyperprolactinemia. Among other causes hyperprolactinemia may be a manifestation of occult pituitary adenoma. Therefore it is suggested that patients with benign breast nodules showing focal secretory change should be screened for clinical and laboratory evidence of hyperprolactinemia. Although it is accepted that in mice and rats prolactin plays an important role in chemically induced mammary tumorigenesis, a consensus has not been reached with regard to its role in man. cancer 50:125-129, 1982.This publication has 6 references indexed in Scilit:
- A Broad Spectrum of Prolactin Suppression by Bromocriptine in Hyperprolactinemic Women: A Study of Serum Prolactin and Bromocriptine Levels after Acute and Chronic Administration ofBromocriptine*Journal of Clinical Endocrinology & Metabolism, 1980
- DNA synthesis of benign human breast tumors in the untreated athymic “Nude” mouse. An in vivo model to study hormonal influences on growth of human breast tissuesCancer, 1980
- Prolactin and human breast cancer: a reviewPublished by Elsevier ,1979
- Brief Communication: In Vitro Stimulation of Human Breast Tissue by Human Prolactin2JNCI Journal of the National Cancer Institute, 1975
- Incidence of chronic cystic disease in so-called “normal breasts”. A study based on 225 postmortem examinationsCancer, 1951